Digital Health Strategy for Acute Kidney Injury
(UPTAKE-1 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve care for individuals who have experienced sudden kidney problems, known as acute kidney injury (AKI), after hospital discharge. Researchers will use digital tools to create personalized care plans, called a risk-guided transition of care intervention, delivered through an integrated digital health strategy. These plans aim to prevent serious health issues like kidney failure or heart attacks. Half of the participants will receive these tailored plans, while the other half will continue with standard care. The trial targets those hospitalized in Alberta with AKI who are at risk of long-term kidney issues.
As an unphased trial, this study offers participants the chance to contribute to innovative care strategies that could enhance recovery and prevent future health complications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your healthcare provider.
What prior data suggests that this digital health strategy is safe for patients with acute kidney injury?
Past studies have shown promise in using digital health methods to care for patients with acute kidney injury (AKI). Research indicates that these methods can create personalized care plans and improve patient outcomes without significant risks. One study found that digital tools guiding care plans increased recommended care for patients at high risk of chronic kidney disease (CKD) after hospital discharge. This suggests that the digital health approach is generally well-received.
While specific data on side effects related to this digital health method is unavailable, similar strategies have been used without major safety concerns. Since the trial uses existing digital tools to customize care plans, it is unlikely to introduce new risks. The trial does not test a new drug or invasive treatment but focuses on improving care through personalized plans, which are usually safe.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a novel digital health strategy for managing acute kidney injury (AKI). Unlike standard care, which typically involves hospital discharge with general follow-up recommendations, this approach uses a risk-guided transition of care. It leverages a risk prediction model combined with a patient's medical profile to create personalized care plans. These plans are integrated into electronic health records, potentially leading to more tailored and effective management from hospital to home, particularly for patients at varying risk levels. This personalized approach could improve outcomes by ensuring that care is specifically aligned with each patient's needs.
What evidence suggests that this digital health strategy is effective for acute kidney injury?
This trial will compare a risk-guided transition of care intervention, delivered through an integrated digital health strategy, with usual care for patients with acute kidney injury (AKI). Research has shown that a targeted approach for patients with AKI can improve their care after hospital discharge. One study found that this approach increased the use of recommended care for those at high risk of long-term kidney issues. Digital tools assist by identifying patients who might face complications, ensuring they receive personalized care plans. This method aims to reduce the chances of serious health problems like kidney failure, heart attacks, and strokes. The strategy could enhance patients' health and experiences as they transition from hospital to home.12346
Who Is on the Research Team?
Neesh Pannu
Principal Investigator
University of Alberta
Matthew James
Principal Investigator
University of Calgary
Tyrone Harrison
Principal Investigator
University of Calgary
Are You a Good Fit for This Trial?
This trial is for adults over 18 in Alberta hospitals who've had a sudden loss of kidney function (acute kidney injury or AKI) and are at risk of future health issues. They must be hospitalized where the AHS electronic health record system is used.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a tailored post-discharge care plan based on their risk of long-term complications after AKI
Follow-up
Participants are monitored for safety and effectiveness after discharge, including kidney function and cardiovascular events
Patient Experience Assessment
Patient experience is assessed using a survey administered 3 months post-discharge
What Are the Treatments Tested in This Trial?
Interventions
- Risk-guided transition of care intervention delivered through an integrated digital health strategy
Trial Overview
The study tests a personalized care plan based on patients' risk levels after an AKI event, using digital tools within Alberta's healthcare EHR. Participants will either receive this tailored plan or standard care, determined randomly.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The proposed experimental intervention will incorporate our risk prediction model which will be used in combination with a patients medical profile to guide the hospital to home transition of care for low, medium and high-risk groups of patients. Patients will receive transition of care plans that are tailored to their medical profile and embedded within standardized discharge pathways within the electronic health record
The usual care group will not receive the risk-guided transition of intervention and will receive standard hospital discharge care in accordance with local health system standards (Alberta Health Services), with recommendations for kidney function, proteinuria and laboratory testing at 90 days after discharge.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alberta
Lead Sponsor
University of Calgary
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Alberta Health services
Collaborator
Published Research Related to This Trial
Citations
Using Personalized Risk and Digital Tools to Guide ...
The investigators will study whether this strategy can reduce health problems that may happen after AKI including death, chronic kidney disease (CKD), kidney ...
Digital health and acute kidney injury: consensus report of the ...
Acute kidney injury (AKI), which is a common complication of acute illnesses, affects the health of individuals in community, acute care and post-acute care ...
Digital Health Strategy for Acute Kidney Injury
What data supports the effectiveness of the treatment Risk-guided transition of care intervention delivered through an integrated digital health strategy ...
4.
journals.lww.com
journals.lww.com/jasn/fulltext/2025/03000/advancing_community_care_and_access_to_follow_up.14.aspxAdvancing Community Care and Access to Follow-Up after...
A risk-guided intervention for patients hospitalized with AKI increased recommended processes of care for CKD for high-risk patients after hospital discharge.
Sustained Improvements After Intervention to Prevent Contrast ...
The main outcome was AKI within 7 days of cardiac catheterization among all participants and those with preexisting chronic kidney disease. In ...
Automated Electronic Alert for the Care and Outcomes of ...
Results of this randomized clinical trial showed that the electronic AKI alert did not improve kidney function or other patient-centered outcomes but changed ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.